Swiss biopharma organization to create Russian Sputnik antibody in Italy
A Swiss biotech organization will produce Russia’s “Sputnik V” COVID-19 antibody in facilities across Italy, the firm declared Monday. Bloomberg News revealed that Adienne Pharma and Biotech reported a deal with Russia’s sovereign wealth fund, the RDIF, to start production close to Milan. The organization plans to have a few million doses manufactured before the…